{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:50:00Z","timestamp":1777402200771,"version":"3.51.4"},"reference-count":14,"publisher":"American Diabetes Association","issue":"12","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We report the case of a woman with PNDM who continued high doses of glibenclamide (85 mg\/day) during her pregnancy. The baby was born preterm, and presented with macrosomia and severe hyperinsulinemic hypoglycemia requiring high-rate intravenous glucose infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Postnatal genetic testing excluded a KCNJ11 mutation in the baby. Glibenclamide was detected in both the baby's blood and the maternal milk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>We hypothesize that high doses of glibenclamide in the mother led to transplacental passage of the drug and overstimulation of fetal \u03b2-cells, which resulted in severe hyperinsulinemic hypoglycemia in the neonate (who did not carry the mutation) and contributed to fetal macrosomia. We suggest that glibenclamide (and other SUs) should be avoided in mothers with PNDM if the baby does not carry the mutation or if prenatal screening has not been performed, while glibenclamide may be beneficial when the fetus is a PNDM carrier.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc14-1247","type":"journal-article","created":{"date-parts":[[2014,9,18]],"date-time":"2014-09-18T07:21:46Z","timestamp":1411024906000},"page":"3333-3335","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":22,"title":["Fetal Macrosomia and Neonatal Hyperinsulinemic Hypoglycemia Associated With Transplacental Transfer of Sulfonylurea in a Mother With <i>KCNJ11<\/i>-Related Neonatal Diabetes"],"prefix":"10.2337","volume":"37","author":[{"given":"Nele","family":"Myngheer","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium"},{"name":"Department of Development and Regeneration, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hattersley","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, Exeter, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"McDonald","sequence":"additional","affiliation":[{"name":"University of Exeter Medical School, Exeter, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Kramer","sequence":"additional","affiliation":[{"name":"University Laboratory of Physiology, Oxford, Oxford, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Ashcroft","sequence":"additional","affiliation":[{"name":"University Laboratory of Physiology, Oxford, Oxford, U.K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Verhaeghe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics\/Gynaecology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium"},{"name":"Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Casteels","sequence":"additional","affiliation":[{"name":"Department of Development and Regeneration, KU Leuven, Leuven, Belgium"},{"name":"Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2014,11,8]]},"reference":[{"key":"2022031219524387900_B1","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031219524387900_B2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0778","article-title":"Clinical implications of a molecular genetic classification of monogenic \u03b2-cell diabetes","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2022031219524387900_B3","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes"},{"key":"2022031219524387900_B4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031219524387900_B5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/AOG.0b013e318190a459","article-title":"Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review","volume":"113","author":"Nicholson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2022031219524387900_B6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","article-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"2022031219524387900_B7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1345\/aph.1K577","article-title":"Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes","volume":"42","author":"Moretti","year":"2008","journal-title":"Ann Pharmacother"},{"key":"2022031219524387900_B8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2010-0096","article-title":"The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy","volume":"95","author":"Klupa","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031219524387900_B9","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.2337\/dc12-0163","article-title":"Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases","volume":"35","author":"Gaal","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031219524387900_B10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0731-7085(91)80136-W","article-title":"Evaluation of solid-phase extraction of basic drugs from human milk","volume":"9","author":"Moors","year":"1991","journal-title":"J Pharm Biomed Anal"},{"key":"2022031219524387900_B11","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1210\/jc.2006-0201","article-title":"Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth and also cause neonatal diabetes","volume":"91","author":"Slingerland","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031219524387900_B12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0002-9378(91)90421-M","article-title":"Insignificant transfer of glyburide occurs across the human placenta","volume":"165","author":"Elliott","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"2022031219524387900_B13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/clpt.2009.5","article-title":"Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice","volume":"85","author":"Hebert","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"2022031219524387900_B14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/diacare.28.8.1851","article-title":"Transfer of glyburide and glipizide into breast milk","volume":"28","author":"Feig","year":"2005","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.2337\/dc19-er07","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000}}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/12\/3333\/618859\/3333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/37\/12\/3333\/618859\/3333.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:37:10Z","timestamp":1647121030000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/37\/12\/3333\/29500\/Fetal-Macrosomia-and-Neonatal-Hyperinsulinemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,8]]},"references-count":14,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,11,8]]},"published-print":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc14-1247","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,8]]}}}